01 • INDUSTRIALIZING INTELLIGENCEFusing science, engineering and high-performance computing to elevate research and drive technological breakthroughs.02 • SCALING BIOINNOVATIONLeading dynamic teams and efforts to launch new products through strategic partnerships that span the global technology landscape.03 • BUILDING INFRASTRUCTUREArchitecting foundational systems to bolster human health, adaptability and resilience to known and emerging challenges of the 21st century.—My life's purpose is to build the future of health.Businesses today face a stark choice: embrace bold innovation or risk irrelevance. I’m currently working with medicine companies to design and implement intelligence platforms that transform core capabilities in SG&A and R&D. These partnerships extend 15 years of experience advancing innovation at the nexus of science, engineering and computing with support from global institutions, including: Bayer, Bristol Myers Squibb, Dana Farber, Emerson Collective, Flagship Pioneering, Mubadala, Sands Capital, Santander, Temasek, and many others.Previously, as CEO of THEONYS, my colleagues and I raised $16M in funding. We assembled a dedicated team to push the boundaries of RNA-focused oncology, reflecting our commitment to solid tumor precision medicines. This experience honed my ability to develop cross-functional organizations, manage global stakeholder networks, and source strategic transactions that deliver shareholder value.—DOCTOR OF SCIENCE • GLOBAL CITIZENLEADER • ENGINEER • COMMUNICATORHEALTH • INTELLIGENCE • RESILIENCE—Google Scholar: https://scholar.google.com/citations?user=24D1ADsAAAAJ